Ioanna Markaki

1.1k total citations
29 papers, 638 citations indexed

About

Ioanna Markaki is a scholar working on Neurology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ioanna Markaki has authored 29 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 8 papers in Epidemiology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ioanna Markaki's work include Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (7 papers) and Acute Ischemic Stroke Management (4 papers). Ioanna Markaki is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (7 papers) and Acute Ischemic Stroke Management (4 papers). Ioanna Markaki collaborates with scholars based in Sweden, United States and United Kingdom. Ioanna Markaki's co-authors include Athena Linos, Evangelia Kaklamani, Christos S. Mantzoros, Virginia Kaklamani, Per Svenningsson, Dimitrios Linos, Yvonni Koumantaki, Panagiota Tsitsi, Konstantinos Kostulas and Christina Sjöstrand and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and European Journal of Cancer.

In The Last Decade

Ioanna Markaki

28 papers receiving 620 citations

Peers

Ioanna Markaki

EDM

NEURO

PHYSI

ONCOL

Wallaya Jongjaroenprasert Thailand

Tianpeng Zheng China

Sébastien Foulquier Netherlands

Austin C. Boese United States

Tal Oron Israel

Francesca Nardi Italy

Yang Qu China

Yasir Abdul United States

Jong‐Jer Lee Taiwan

Wallaya Jongjaroenprasert Thailand

Ioanna Markaki

128 ×0.6

EDM

327 ×1.9

238 ×1.6

NEURO

132 ×1.1

PHYSI

28 ×0.3

ONCOL

Citations per year, relative to Ioanna Markaki Ioanna Markaki (= 1×) peers Wallaya Jongjaroenprasert

Countries citing papers authored by Ioanna Markaki

Since Specialization

Citations

This map shows the geographic impact of Ioanna Markaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ioanna Markaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ioanna Markaki more than expected).

Fields of papers citing papers by Ioanna Markaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ioanna Markaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ioanna Markaki. The network helps show where Ioanna Markaki may publish in the future.

Co-authorship network of co-authors of Ioanna Markaki

This figure shows the co-authorship network connecting the top 25 collaborators of Ioanna Markaki. A scholar is included among the top collaborators of Ioanna Markaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ioanna Markaki. Ioanna Markaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pasławski, Wojciech, Ioanna Markaki, Michael A. Nalls, et al.. (2025). High Cerebrospinal DOPA Decarboxylase Level Predicts Cognitive Decline in Parkinson's Disease. Movement Disorders Clinical Practice. 13(3). 791–794.

Phokaewvarangkul, Onanong, et al.. (2025). Vital nutrition: enhancing health in advanced Parkinson’s disease with device-aided therapies. Journal of Neural Transmission. 132(11). 1685–1697. 1 indexed citations

Svenningsson, Per, Per Odin, Filip Bergquist, et al.. (2025). NLX‐112 Randomized Phase 2A Trial: Safety, Tolerability, Anti‐Dyskinetic, and Anti‐Parkinsonian Efficacy. Movement Disorders. 40(6). 1134–1142. 3 indexed citations

Bergquist, Filip, Per Odin, Anders Johansson, et al.. (2024). Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease. European Journal of Neurology. 32(1). e16582–e16582. 3 indexed citations

Hye, Abdul, Latha Velayudhan, B. Bloth, et al.. (2023). Complement system changes in blood in Parkinson's disease and progressive Supranuclear Palsy/Corticobasal Syndrome. Parkinsonism & Related Disorders. 108. 105313–105313. 11 indexed citations

Tsitsi, Panagiota, Mattias Nilsson, Gustaf Öqvist Seimyr, et al.. (2023). Reading Alterations in Parkinson's Disease Indicate Worse Cognitive Status. Movement Disorders Clinical Practice. 10(4). 579–585. 6 indexed citations

Tsitsi, Panagiota, Mattias Nilsson, Josefine Waldthaler, et al.. (2023). Pupil light reflex dynamics in Parkinson’s disease. Frontiers in Integrative Neuroscience. 17. 1249554–1249554. 5 indexed citations

Pasławski, Wojciech, et al.. (2023). Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease. Translational Neurodegeneration. 12(1). 42–42. 21 indexed citations

Markaki, Ioanna, et al.. (2022). Mechanical thrombectomy in stroke patients of working age: Real-world outcomes in Sweden. European Stroke Journal. 7(1). 41–47. 3 indexed citations

10.

Ran, Caroline, Sandra Gellhaar, Marie Westerlund, et al.. (2022). Glucocerebrosidase variant T369M is not a risk factor for Parkinson’s disease in Sweden. Neuroscience Letters. 784. 136767–136767. 3 indexed citations

11.

Tsitsi, Panagiota, Mattias Nilsson, Gustaf Öqvist Seimyr, et al.. (2021). Fixation Duration and Pupil Size as Diagnostic Tools in Parkinson’s Disease. Journal of Parkinson s Disease. 11(2). 865–875. 38 indexed citations

12.

Markaki, Ioanna, Kristian Hillert Winther, Sergiu‐Bogdan Catrina, & Per Svenningsson. (2020). Repurposing GLP1 agonists for neurodegenerative diseases. International review of neurobiology. 155. 91–112. 10 indexed citations

13.

Kastorini, Christina-Maria, Ioanna Markaki, Thomas Tsiampalis, et al.. (2020). Dietary patterns and food insecurity of students participating in a food aid programme: the Mediterranean perspective. European Journal of Public Health. 31(1). 143–150. 8 indexed citations

14.

Green, Holly, Panagiota Tsitsi, Ioanna Markaki, Dag Aarsland, & Per Svenningsson. (2019). Novel Treatment Opportunities Against Cognitive Impairment in Parkinson’s Disease with an Emphasis on Diabetes-Related Pathways. CNS Drugs. 33(2). 143–160. 19 indexed citations

15.

Markaki, Ioanna, et al.. (2017). Elevated plasma homocysteine upon ischemic stroke is associated with increased long-term mortality in women. PLoS ONE. 12(8). e0183571–e0183571. 4 indexed citations

16.

Markaki, Ioanna, et al.. (2013). Long-Term Survival of Ischemic Cerebrovascular Disease in the Acute Inflammatory Stroke Study, a Hospital-Based Cohort Described by TOAST and ASCO. Cerebrovascular Diseases. 35(3). 213–219. 20 indexed citations

17.

Markaki, Ioanna, et al.. (2013). High Cholesterol Levels Are Associated with Improved Long-term Survival after Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. 23(1). e47–e53. 47 indexed citations

18.

Kostulas, Nikolaos, et al.. (2009). Hyperglycaemia in acute ischaemic stroke is associated with an increased 5-year mortality. Age and Ageing. 38(5). 590–594. 22 indexed citations

19.

Solakidi, Sylvia, Kalliopi Petraki, George P. Stathopoulos, et al.. (2003). Co-expression of trypsin and tumour-associated trypsin inhibitor (TATI) in colorectal adenocarcinomas.. PubMed. 18(4). 1181–8. 18 indexed citations

20.

Markaki, Ioanna, Dimitrios Linos, & Athena Linos. (2003). The influence of dietary patterns on the development of thyroid cancer. European Journal of Cancer. 39(13). 1912–1919. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact